Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression of thyroiditis

V C Guimaraes1, J Quintans, M E Fisfalen

  • 1Department of Medicine, University of Chicago, Illinois 60637, USA.

Endocrinology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression.

Endocrine·2012
Same author

Oral ingestion of a hydrolyzed gelatin meal in subjects with normal weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and insulin.

Eating and weight disorders : EWD·2008
Same author

Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin.

Journal of endocrinological investigation·2007
Same author

The anorectic effect of increasing doses of L-tryptophan in obese patients.

Eating and weight disorders : EWD·2003
Same author

Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Journal of endocrinological investigation·2002
Same author

Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.

Gene therapy·2002
Same journal

Zingerone ameliorates ovarian impairment by regulating steroidogenesis and apoptosis in letrozole-treated mouse.

Endocrinology·2026
Same journal

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Endocrinology·2026
Same journal

Long Non-Coding RNAs Mediate Endocrine Signaling and Resistance in Prostate Cancer.

Endocrinology·2026
Same journal

Repeated Chemogenetic Activation of C1 Catecholamine Neurons Reduces Subsequent Glucoprivic Responses and Mimics HAAF.

Endocrinology·2026
Same journal

Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice.

Endocrinology·2026
Same journal

Discovery proteomics identification of factors contributing to gonadotropin β expression.

Endocrinology·2026
See all related articles

Oral administration of thyroglobulin (TG) induces antigen-specific immune tolerance in mice, suppressing inflammatory responses. This mechanism involves a shift to regulatory T cells producing immunosuppressive cytokines, offering insights into autoimmune disease treatment.

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Immunization with human thyroglobulin (TG) induces experimental autoimmune thyroiditis in mice, characterized by thyroid inflammation and anti-TG antibody production.
  • Oral administration of antigens can induce immune tolerance, a phenomenon with potential therapeutic applications in autoimmune diseases.
  • The precise mechanisms underlying antigen-specific oral tolerization remain incompletely understood.

Purpose of the Study:

  • To elucidate the cellular and molecular mechanisms responsible for antigen-specific oral tolerization induced by thyroglobulin (TG) in a mouse model.
  • To investigate the role of cytokine profiles and T cell subsets in mediating oral tolerance.
  • To explore the potential relevance of this model to human autoimmune thyroid disease.

Main Methods:

Related Experiment Videos

  • Mice were immunized with TG to induce thyroiditis and immune responses.
  • Oral administration of TG was employed before and after immunization to induce tolerance.
  • Immune responses, including antibody production, lymphocyte proliferation, and cytokine profiles (IL-2, IFN-γ, IL-4, TGF-β), were assessed in lymphoid organs (PLN, MLN, spleen).

Main Results:

  • Oral TG administration significantly suppressed immune responses to TG, including antibody production and lymphocyte proliferation, in a dose-dependent and antigen-specific manner.
  • Tolerized animals exhibited reduced lymph node size and a distinct cytokine profile, characterized by increased IL-4 and TGF-β production and decreased IL-2 and IFN-γ.
  • CD8+ T cells from tolerized animals produced IL-4 and TGF-β and induced suppression, while CD4+ T cells produced IL-2 and IFN-γ.

Conclusions:

  • Oral tolerization with TG shifts the immune response from a Th-1 to a Th-2/immunosuppressive phenotype, mediated by regulatory T cells.
  • These regulatory cells, induced by oral antigen exposure, migrate to lymphoid tissues and suppress specific and non-specific immune responses.
  • This experimental model provides valuable insights into the mechanisms of oral tolerance and its potential application in managing autoimmune thyroid diseases.